สมัครสมาชิก

เข้าสู่ระบบ

Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee’s Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia

License Transfer from Solasia to Lee’s Pharm for the Sales Promotion of Sancuso® and episil® in three cities in China

ดาวน์โหลดข่าวฉบับเต็ม (PDF)

ที่มา: Lee’s Pharmaceutical Holdings – News & Media

ข่าวสารอื่นๆ

Lee’s Pharm participated in BIOHK2023 and won the “Best Pharmaceutical Company of the Year Award”

September 18, 2023
Lee’s Pharm participated in BIOHK2023 and won the “Best Pharmaceutical Company of the Year Award”

East Meets West – Lee’s Pharm 9th Perinatal Medical Forum in Beijing

September 1, 2019
East Meets West – Lee’s Pharm 9th Perinatal Medical Forum in Beijing

Zhaoke Hefei was honored with the 2024 “New Force Enterprise” of Hefei High-tech Zone

January 7, 2025
Zhaoke Hefei was honored with the 2024 “New Force Enterprise” of Hefei High-tech Zone

In-licensed product Natulan® (Procarbazine Hydrochloride Capsules) was successfully launched in China

May 2, 2023
In-licensed product Natulan® (Procarbazine Hydrochloride Capsules) was successfully launched in China

Donation of ERT-PCR Technology for New Coronavirus Detection Press Conference

March 3, 2020
Donation of ERT-PCR Technology for New Coronavirus Detection Press Conference

Lee’s Pharm was honoured with “2021 Top 100 Chinese Chemical Pharmaceutical Companies” Award

July 16, 2022
Lee’s Pharm was honoured with “2021 Top 100 Chinese Chemical Pharmaceutical Companies” Award
en_USEnglish
thThai en_USEnglish